Predicting fluorouracil toxicity: can we finally do it?

J Clin Oncol. 2008 May 1;26(13):2080-2. doi: 10.1200/JCO.2007.15.5481. Epub 2008 Feb 25.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antimetabolites, Antineoplastic / adverse effects*
  • Diarrhea / chemically induced
  • Diarrhea / etiology*
  • Diarrhea / genetics
  • Dihydrouracil Dehydrogenase (NADP) / genetics
  • Fluorouracil / adverse effects*
  • Genetic Predisposition to Disease
  • Genetic Testing*
  • Humans
  • Leucovorin / adverse effects
  • Leukopenia / chemically induced
  • Leukopenia / etiology*
  • Leukopenia / genetics
  • Logistic Models
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Mucositis / chemically induced
  • Mucositis / etiology*
  • Mucositis / genetics
  • Odds Ratio
  • Patient Selection
  • Polymorphism, Genetic*
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Thymidylate Synthase / genetics
  • Vitamin B Complex / adverse effects

Substances

  • Antimetabolites, Antineoplastic
  • Vitamin B Complex
  • Dihydrouracil Dehydrogenase (NADP)
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Thymidylate Synthase
  • Leucovorin
  • Fluorouracil